Product Details
Product Name:
SR-3029 |
CAS No.:
1454585-06-8 |
Purity:
99.64% |
Supply Ability:
10g |
Release date:
2024/11/19 |
Product Introduction
Bioactivity
Name | SR-3029 |
Description | SR-3029 is a highly potent and specific inhibitor of CK1δ/CK1ε. |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO : 45 mg/mL (93.66 mM)
|
Keywords | Inhibitor | Casein Kinase | inhibit | SR-3029 | SR 3029 |
Inhibitors Related | TBCA | CK2-IN-4 | Ellagic acid | Casein Kinase II Inhibitor IV | CK2α-IN-1 | Emodin | LY-364947 | AS-252424 | TA-01 | CK2/ERK8-IN-1 | Casein kinase 1δ-IN-6 | LY294002 |
Related Compound Libraries | Bioactive Compound Library | Kinase Inhibitor Library | Inhibitor Library | NO PAINS Compound Library | Stem Cell Differentiation Compound Library | Metabolism Compound Library | Bioactive Compounds Library Max | Wnt/Hedgehog/Notch Compound Library | Anti-Metabolism Disease Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
CAS:1164153-22-3
$290.00 / 5mg
-
CAS:2597186-19-9
$58.00 / 1mg
-
CAS:2095432-55-4
$34.00 / 2mg
Recommended supplier
Product name |
Price |
|
Suppliers |
Update time |
|
$40.00/1Box |
|
zhuzhou dingcheng meihei comestic co.,ltd
|
2024-05-29 |
|
$20.00/1kg |
VIP1Y
|
Shaanxi Franta Biotechnology Co., Ltd
|
2024-09-23 |
|
$297.00/5mg |
VIP1Y
|
TargetMol Chemicals Inc.
|
2024-10-23 |